Alternative Treatment with Every-Other-Day Dosing of Sunitinib for Metastatic Renal Cell Carcinoma: Extended Follow-Up
Sign Up to like & getrecommendations! Published in 2022 at "Urologia Internationalis"
DOI: 10.1159/000520652
Abstract: Introduction: We investigated the efficacy and safety of every-other-day dosing of sunitinib for the treatment of metastatic renal cell carcinoma (mRCC) with extended follow-up and the impact of immune checkpoint inhibitor (ICI) drugs. Methods: Thirty-two… read more here.
Keywords: day; every day; dosing sunitinib; day dosing ... See more keywords